全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

肺结节研究进展
Research Progress of Pulmonary Nodules

DOI: 10.12677/tcm.2024.135157, PP. 1026-1035

Keywords: 肺结节,随访管理,干预措施
Pulmonary Nodules
, Follow-Up Management, Intervention Measures

Full-Text   Cite this paper   Add to My Lib

Abstract:

肺结节的治疗痛点在于其良恶性难以鉴别、随访周期长且容易演变为肺癌,以及现有治疗手段的局限性。西医学对于肺结节早期干预及其恶变后的处理缺少对应的治疗,在早期多以随访管理为主,无针对性有效药物。因此,如何有效地早期干预肺结节的进展,成为临床工作中的一大难题。本文旨在综述肺结节的流行病学、定义和分类、肺结节评估及恶性风险预测模型,肺结节的随访管理及目前针对肺结节的中西医干预措施。通过归纳整理这些信息,可以为未来的肺结节进一步研究和临床工作提供必要的参考和指导。
The pain points in the treatment of pulmonary nodules lie in the difficulty in distinguishing between benign and malignant, the long follow-up period, and the tendency to evolve into lung cancer, as well as the limitations of existing treatment methods. Western medicine lacks corresponding treatment for early intervention and management of malignant transformation of pulmonary nodules, and in the early stages, follow-up management is mainly used without targeted and effective drugs. Therefore, how to effectively intervene in the progression of pulmonary nodules in the early stage has become a major challenge in clinical work. This article aims to review the epidemiology, definition and classification of pulmonary nodules, pulmonary nodule assessment and malignant risk prediction models, follow-up management of pulmonary nodules, and current Chinese and Western medicine interventions for pulmonary nodules. By summarizing and organizing this information, it can provide necessary reference and guidance for further research and clinical work on pulmonary nodules in the future.

References

[1]  Randhawa, S., Drizin, G., Kane, T., Song, G.Y., Reilly, T. and Jarrar, D. (2018) Lung Cancer Screening in the Community Setting: Challenges for Adoption. The American Surgeon, 84, 1415-1421.
https://doi.org/10.1177/000313481808400942
[2]  Bach, P.B., Mirkin, J.N., Oliver, T.K., et al. (2012) Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review. JAMA, 307, 2418-2429.
https://doi.org/10.1001/jama.2012.5521
[3]  中华医学会呼吸病学分会肺癌学组, 中国肺癌防治联盟专家组. 肺结节诊治中医专家共识(2018年版) [J]. 中华结核和呼吸杂病, 2018, 41(10): 763-771.
[4]  刘玉萍, 冯刚. 体检人群低剂量CT早期肺癌筛查结果及危险因素分析[J]. 中华老年医学杂志, 2017, 36(11): 1242-1246.
[5]  Zeng, H., Zheng, R., Guo, Y., et al. (2015) Cancer Survival in China, 2003-2005: A Population-Based Study. International Journal of Cancer, 136, 1921-1930.
https://doi.org/10.1002/ijc.29227
[6]  苏雷, 魏秀芹. 从我国肺癌防控发展看早期肺癌的诊疗策略[J]. 医学研究杂志, 2020, 49(9): 1-5.
[7]  Sung, H., Ferlay, J., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
[8]  中国肿瘤科相关专家小组. 中国肺部结节分类、诊断与治疗指南(2016年版) [J]. 中国肺癌杂志, 2016, 19(12): 793-798.
[9]  夏宇, 刘琪, 赵天天, 等. 肺结节的中西医临床研究进展[J]. 云南中医中药杂志, 2024, 45(1): 97-100.
[10]  李小雪, 蒲红, 尹芳艳, 等. 肺部结节的诊疗新进展[J]. 放射学实践, 2019, 34(5): 578-582.
[11]  崔舒蕾, 王建卫. 肺磨玻璃结节干预策略[J]. 中华肿瘤防治杂志, 2024, 31(4): 233-240.
[12]  吴勇, 武强, 曾强, 等. 低剂量螺CT对35686例健康体检者的肺癌筛查分析[J]. 中华保健医学杂志, 2014, 2(16): 24-27.
[13]  何爽, 田金, 龙麟, 等. 肺癌筛查与早期诊断: 从影像学到生物标志物的进展[J]. 中国癌症防治杂志, 2024, 16(1): 120-126.
[14]  Simmons, J., Gould, M.K., Iaccarino, J., et al. (2016) Systems-Level Resources for Pulmonary Nodule Evaluation in the United States: A National Survey. American Journal of Respiratory and Critical Care Medicine, 193, 1063-1065.
https://doi.org/10.1164/rccm.201511-2163LE
[15]  陈婧, 叶晓丹. 肺结节处理指南的解读和比较[J]. 中国中西医结合影像学杂志, 2021, 19(3): 301-306.
[16]  Shen, H. (2018) Low-Dose CT for Lung Cancer Screening: Opportunities and Challenges. Frontiers in Medicine, 12, 116-121.
https://doi.org/10.1007/s11684-017-0600-1
[17]  陈勇, 吴俊, 陆世春, 等. 18F-FDG PET/CT联合CT三维重建在肺结节良恶性鉴别中的应用[J]. 中国胸心血管外科临床杂志, 2024: 1-7.
[18]  刘瑛, 吴宁, 郑容, 等. 良性肺结节在18F-FDG PET-CT上的摄取特点[J]. 癌症进展, 2015, 13(2): 213-217.
[19]  邵晓梁, 牛荣, 王跃涛, 等. 基于(18)F-FDGPET/CT的磨玻璃结节早期肺腺癌浸润性预测模型的构建及验证[J]. 中华核医学与分子影像杂志, 2022, 42(7): 385-390.
[20]  Tang, Z.M., Ling, Z.G., Wang, C.M., et al. (2017) Serum Tumor-Associated Autoantibodies as Diagnostic Biomarkers for Lung Cancer: A Systematic Review and Meta-Analysis. PLOS ONE, 12, e0182117.
https://doi.org/10.1371/journal.pone.0182117
[21]  Ren, S., Zhang, S., Jiang, T., et al. (2017) Early Detection of Lung Cancer by Using an Autoantibody Panel in Chinese Population. Oncoimmunology, 7, e1384108.
https://doi.org/10.1080/2162402X.2017.1384108
[22]  Vieler, M. and Sanyal, S. (2018) P53 Isoforms and Their Implications in Cancer. Cancers (Basel), 10, Article No. 288.
https://doi.org/10.3390/cancers10090288
[23]  Guan, Y.J., Yu, J. and Wang, W.X. (2022) Research Advances of Transcription Factors and Tumor Metabolic Reprogramming. Journal of Abdominal Surgery, 35, 136-140.
[24]  Chou, Y.T., Lee, C.C., Hsiao, S.H., et al. (2013) The Emerging Role of SOX2 in Cell Proliferation and Survival and Its Crosstalk with Oncogenic Signaling in Lung Cancer. Stem Cells, 31, 2607-2619.
https://doi.org/10.1002/stem.1518
[25]  Hibi, K., Westra, W.H., Borges, M., et al. (1999) PGP9.5 as a Candidate Tumor Marker for Non-Small-Cell Lung Cancer. The American Journal of Pathology, 155, 711-715.
https://doi.org/10.1016/S0002-9440(10)65169-3
[26]  王晶, 翟成凯. 肿瘤自身抗体及CT人工智能在NSCLC早期诊断中的研究进展[J]. 解放军医学杂志, 2024: 1-11.
[27]  Lambin, P., Rios-Velazquez, E., Leijenaar, R., et al. (2012) Radiomics: Extracting More Information from Medical Images Using Advanced Feature Analysis. European Journal of Cancer, 48, 441-446.
https://doi.org/10.1016/j.ejca.2011.11.036
[28]  宫进昌, 赵尚义, 王远军. 基于深度学习的医学图像分割研究进展[J]. 中国医学物理学杂志, 2019, 36(4): 420-424.
[29]  Chamberlin, J., Kocher, M.R., Waltz, J., et al. (2021) Automated Detection of Lung Nodules and Coronary Artery Calcium Using Artificial Intelligence on Low-Dose CT Scans for Lung Cancer Screening: Accuracy and Prognostic Value. BMC Medicine, 19, Article No. 55.
https://doi.org/10.1186/s12916-021-01928-3
[30]  Wahidi, M.M., Herth, F., Yasufuku, K., et al. (2016) Technical Aspects of Endobronchial Ultrasound?Guided Transbronchial Needle Aspiration: CHEST Guideline and Expert Panel Report. Chest, 149, 816?835.
https://doi.org/10.1378/chest.15-1216
[31]  徐海燕. 肺癌自身抗体联合肿瘤标志物检测诊断早期肺癌的价值[J]. 基层医学论坛, 2024, 28(5): 101-103.
[32]  孙莲, 红萍, 吴文英. 结节诊断及手术治疗的研究进展[J]. 标记免疫分析与临床, 2023(8): 1431-1434.
[33]  王立学, 鸿鹏, 博锋. T引导下经皮肺穿刺活检对不同大小肺结节的诊断效能及并发症相关因素分析[J]. 放射学实践, 2020, 35(11): 1409-1414.
[34]  中国临床肿瘤学会(CSCO)老年肿瘤防治专家委员会. 导航引导下经支气管肺结节介入诊断与治疗中国专家共识[J]. 解放军医学杂志, 2023, 48(9): 993-999.
[35]  赫捷, 李霓, 陈万青, 等. 中国肺癌筛查与早诊早治指南(2021, 北京) [J]. 中华肿瘤杂志, 2021, 43(3): 243-268.
[36]  Swensen, S.J., Ilverstein, M.D., Lstrup, D.M., et al. (1997) The Probability of Malignancy in Solitary Pulmonary Nodules: Application to Small Radiologically Indeterminate Nodules. Archives of Internal Medicine, 157, 849-855.
https://doi.org/10.1001/archinte.1997.00440290031002
[37]  Gould, M.K., Ananth, L. and Barnett, P.G. (2007) A Clinical Model to Estimate the Pretest Probability of Lung Cancer in Patients with Solitary Pulmonary Nodules. Chest, 131, 383-388.
https://doi.org/10.1378/chest.06-1261
[38]  Tanner, N.T., Porter, A., Gould, M.K., et al. (2017) Physician Assessment of Pretest Probability of Malignancy and Adherence with Guidelines for Pulmonary Nodule Evaluation. Chest, 152, 263-270.
https://doi.org/10.1016/j.chest.2017.01.018
[39]  Yu, S.B., Baek, J., Choi, M., et al. (2016) Polymer Thin Films with Tunable Acetylcholine-Like Functionality Enable Long-Term Culture of Primary Hippocampal Neurons. ACS Nano, 10, 9909-9918.
https://doi.org/10.1021/acsnano.6b03527
[40]  Zhang, M., Zhuo, N., Guo, Z., et al. (2015) Establishment of a Mathematic Model for Predicting Malignancy in Solitary Pulmonary Nodules. Journal of Thoracic Disease, 7, 1833-1841.
[41]  Muller, D.C., Johansson, M. and Brennan, P. (2017) Lung Cancer Risk Prediction Model Incorporating Lung Function: Development and Validation in the UK Biobank Prospective Cohort Study. Journal of Clinical Oncology, 35, 861-869.
https://doi.org/10.1200/JCO.2016.69.2467
[42]  Gray, E.P., Teare, M.D., Stevens, J., et al. (2016) Risk Prediction Models for Lung Cancer: A Systematic Review. Clinical Lung Cancer, 17, 95-106.
https://doi.org/10.1016/j.cllc.2015.11.007
[43]  Sakoda, L.C., Henderson, L.M., Caverly, T.J., et al. (2017) Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions. Current Epidemiology Reports, 4, 307-320.
https://doi.org/10.1007/s40471-017-0126-8
[44]  周舒畅, 王玉锦, 胡琼洁, 等. RSNA2016胸部影像学[J]. 放射学实践, 2017, 32(1): 8-15.
[45]  赫捷, 李霓, 陈万青, 等. 中国肺癌筛查与早诊早治指南(2021, 北京) [J]. 中国肿瘤, 2021, 30(2): 81-111.
[46]  Hansell, D.M., Bankier, A.A., MacMahon, H., et al. (2008) Fleischner Society: Glossary of Terms for Thoracic Imaging. Radiology, 246, 697-722.
https://doi.org/10.1148/radiol.2462070712
[47]  Kim, Y.W., Kwon, B.S., Lim, S.Y., et al. (2021) Lung Cancer Probability and Clinical Outcomes of Baseline and New Subsolid Nodules Detected on Low-Dose CT Screening. Thorax, 76, 980-988.
https://doi.org/10.1136/thoraxjnl-2020-215107
[48]  Fan, L., Wang, Y., Zhou, Y., et al. (2019) Lung Cancer Screening with Low Dose CT: Baseline Screening Results in Shanghai. Academic Radiology, 26, 1283-1291.
https://doi.org/10.1016/j.acra.2018.12.002
[49]  Tang, E.K., Chen, C.S., Wu, C.C., et al. (2019) Natural History of Persistent Pulmonary Subsolid Nodules: Long-Term Observation of Different Interval Growth. Heart, Lung and Circulation, 28, 1747-1754.
https://doi.org/10.1016/j.hlc.2018.08.015
[50]  Gould, M.K., Donington, J., Lynch, W.R., et al. (2013) Evaluation of Individuals with Pulmonary Nodules: When Is It Lung Cancer? Diagnosis and Management of Lung Cancer, 3rd Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 143, E93S-E120S.
https://doi.org/10.1378/chest.12-2351
[51]  Naidich, D.P., Bankier, A.A., MacMahon, H., et al. (2013) Recommendations for the Management of Subsolid Pulmonary Nodules Detected at CT: A Statement from the Fleischner Society. Radiology, 266, 304-317.
https://doi.org/10.1148/radiol.12120628
[52]  Baldwin, D.R. and Callister, M.E. (2015) The British Thoracic Society Guidelines on the Investigation and Management of Pulmonary Nodules. Thorax, 70, 794-798.
https://doi.org/10.1136/thoraxjnl-2015-207221
[53]  Bai, C., Choi, C.M., Chu, C.M., et al. (2016) Evaluation of Pulmonary Nodules: Clinical Practice Consensus Guidelines for Asia. Chest, 150, 877-893.
https://doi.org/10.1016/j.chest.2016.02.650
[54]  Wu, W.B., Xu, X.F., Wen, W., et al. (2016) Three-Dimensional Computed Tomography Bronchography and Angiography in the Preoperative Evaluation of Thoracoscopic Segmentectomy and Subsegmentectomy. Journal of Thoracic Disease, 8, S710-S715.
https://doi.org/10.21037/jtd.2016.09.43
[55]  中国医药教育协会肺癌医学教育委员会. 肺结节多学科微创诊疗中国专家共识[J]. 中国胸心血管外科临床杂志, 2023: 1-14.
[56]  肖飞, 余其多, 张真榕, 等. 新型非实性肺小结节恶性概率预测. 模型的构建与验证[J]. 中国肺癌杂志, 2019, 22(1): 26-33.
[57]  Tammem?gi, M.C., Katki, H.A., Hocking, W.G., et al. (2013) Selection Criteria for Lung-Cancer Screening. The New England Journal of Medicine, 368, 728-736.
https://doi.org/10.1056/NEJMoa1211776
[58]  张潇文, 朱晓雷, 刘鸿鸣. 等. 多学科诊疗团队模式下的肺癌诊疗一体化[J]. 中国胸心血管外科临床杂志, 2022, 29(7): 806-811.
[59]  叶欣, 范卫君, 王忠敏, 等. 热消融治疗肺部亚实性结节专家共识(2021年版) [J]. 中国肺癌杂志, 2021, 24(5): 305-322.
[60]  乔元岗, 刘现闯, 鲍志宇, 等. 活检同步微波消融治疗肋胸膜下肺结节的安全性及有效性[J]. 医学影像学杂志, 2023, 33(8): 1386-1389.
[61]  Iguchi, T., Hiraki, T., Gobara, H., et al. (2015) Percutaneous Radiofrequency Ablation of Lung Cancer Presenting as Ground-Glass Opacity. CardioVascular and Interventional Radiology, 38, 409-415.
https://doi.org/10.1007/s00270-014-0926-x
[62]  Yang, X., Ye, X., Lin, Z., et al. (2018) Computed Tomography-Guided Percutaneous Microwave Ablation for Treatment of Peripheral Ground-Glass Opacity Lung Adenocarcinoma: A Pilot Study. Journal of Cancer Research and Therapeutics, 14, 764-771.
https://doi.org/10.4103/jcrt.JCRT_269_18
[63]  孙莲, 马红萍, 吴文英. 肺结节诊断及手术治疗的研究进展[J]. 标记免疫分析与临床, 2023, 30(8): 1431-1440.
[64]  Huang, G., Yang, X., Li, W., et al. (2020) A Feasibility and Safety Study of Computed Tomography-Guided Percutaneous Microwave Ablation: A Novel Therapy for Multiple Synchronous Ground-Glass Opacities of the Lung. International Journal of Hyperthermia, 37, 414-422.
https://doi.org/10.1080/02656736.2020.1756467
[65]  陈亚玲, 倪锴文, 王真. 王真教授治疗肺部结节的经验[J]. 浙江中医药大学学报, 2020, 44(10): 977-979.
[66]  王英, 何荣平, 朱建平, 等. “肝为主体, 脾肾为侧翼, 疏调人体气机”论治肺结节经验[J]. 环球中医药, 2023, 16(1): 135-137.
[67]  郭军, 刘国安. 刘国安教授辨证论治肺结节病经验[J]. 甘肃中医, 2009, 22(10): 1.
[68]  刘羿彤, 李猛, 马战平. 从痰论治肺结节的炎性微环境[J]. 长春中医药大学学报, 2020, 36(4): 620-623.
[69]  周杰, 王玥慧, 李志明, 等. 络病学说指导下的肺结节“肺气亏虚, 毒阻肺络”病机探讨[J]. 中国医药导报, 2020, 17(28): 133-136.
[70]  洪海都, 刘城鑫, 吴鹏, 等. 刘小虹辨治肺结节中医特色探析[J]. 中国中医基础医学杂志, 2020, 26(4): 539-541.
[71]  赵峰云, 张盼盼, 郑小伟. 肺结节病临证辨治体会[J]. 浙江中医杂志, 2018, 53(2): 121.
[72]  朱丽娜, 刘丽坤. 中医治疗孤立性肺结节思路探讨[J]. 亚太传统医药, 2019, 15(2): 79-81.
[73]  许海柱, 潘永福. 潘永福教授治疗孤立性肺小结节的用药规律探析[J]. 中医药学报, 2018, 46(5): 93-96.
[74]  刘敏, 朱佳. 朱佳教授治疗肺结节中医思路[J]. 辽宁中医药大学学报, 2018, 20(9): 89-91.
[75]  王琳琳, 庞立健, 王娜娜, 等. 肺结节中医诊疗思路与方法[J]. 中华中医药杂志, 2022, 37(3): 1258-1262.
[76]  马秀霞, 孟鹏飞, 陈关征, 等. 肺结节的中西医认识概况[J]. 中医研究, 2021, 34(7): 59-62.
[77]  谭可欣, 郑佳彬, 张旭, 等. 中医药在肺结节全程管理中的优势及展望[J]. 中医杂志, 2022, 63(14): 1388-1393.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133